Skip to main content

Biopharma

Single-Use Bioprocessing APAC 2028

Date
16–17 May 2028
Location
Singapore

Overview

Biopharmaceutical manufacturing across Asia-Pacific is evolving towards greater flexibility, speed and operational agility, as manufacturers respond to increasingly diverse pipelines, changing production volumes and the need to bring new therapies to patients more efficiently. Single-use technologies are playing an increasingly important role in this transformation, enabling more flexible facility designs, faster changeovers and adaptable manufacturing strategies across clinical and commercial production.

Across Singapore, South Korea, Japan, China, Taiwan, India and Southeast Asia, biopharmaceutical manufacturers and CDMOs continue to expand and modernise their manufacturing capabilities. As facilities become more flexible and multi-product, the industry is increasingly focused on how single-use systems can be effectively implemented, scaled and integrated while addressing challenges around process robustness, automation, supply security, extractables and leachables, sustainability and regulatory compliance.

Taking place on 16–17 May 2028 in Singapore, Single-Use Bioprocessing APAC 2028 will bring together biopharmaceutical manufacturers, CDMOs, technology providers and industry experts from across Asia-Pacific to explore the latest strategies and technologies shaping the future of single-use bioprocessing from process development and facility design through to commercial-scale manufacturing.

The conference will explore single-use upstream and downstream processing, fluid management, mixing, filtration, process intensification, facility and process design, automation and digital integration, extractables and leachables, supply-chain resilience and sustainability — providing a focused platform for the industry to exchange practical experience, discover new technologies and advance the next generation of flexible biopharmaceutical manufacturing across APAC.

Programme

Day 1 — Tuesday 16 May 2028

  • 08:30

    Registration & Welcome Coffee

  • 09:00

    Chairperson's Welcome & Opening Remarks

  • 09:10

    SESSION I: SINGLE-USE BIOPROCESSING APAC - STRATEGY, ADOPTION & THE FLEXIBLE FACTORY

  • 10:25

    Morning Networking Break & Exhibition Viewing

  • 11:10

    SESSION II: SINGLE-USE BIOREACTORS, CELL CULTURE & PROCESS INTENSIFICATION

  • 12:25

    Networking Lunch & Exhibition Viewing

  • 13:40

    SESSION III: FLUID MANAGEMENT, BAGS, TUBING & ASEPTIC CONNECTIONS

  • 14:55

    Afternoon Networking Coffee & Exhibition Viewing

  • 15:40

    SESSION IV: FILTRATION, DOWNSTREAM & SINGLE-USE PURIFICATION

  • 17:00

    End of Day 1 — Single-Use Bioprocessing APAC 2028, Networking Reception

Day 2 — Wednesday 17 May 2028

  • 09:10

    SESSION V: QUALIFICATION, EXTRACTABLES & LEACHABLES, INTEGRITY & RISK

  • 10:25

    Morning Networking Break & Exhibition Viewing

  • 11:10

    SESSION VI: AUTOMATION, SENSORS, PAT & DIGITAL INTEGRATION

  • 12:25

    Networking Lunch & Exhibition Viewing

  • 13:40

    SESSION VII: SUPPLY CHAIN, STANDARDISATION & LOCALISATION

  • 14:55

    Afternoon Networking Coffee & Exhibition Viewing

  • 15:40

    SESSION VIII: SUSTAINABILITY, HYBRID FACILITIES & BIOPROCESSING 2035

  • 17:00

    End of Conference

Who Attends

Function

  • Process Development / MSAT / Manufacturing Operations22%
  • Upstream Processing / Cell Culture18%
  • Downstream Processing / Purification / Filtration16%
  • Engineering / Facilities / Automation12%
  • Quality / Validation / E&L / Supplier Quality12%
  • Tech Transfer / CMC6%
  • Procurement / Supply Chain / Strategic Sourcing6%
  • Others / BD / Marketing / Management8%

By Country / Region

  • Singapore25%
  • South Korea / Japan20%
  • China / Taiwan / Hong Kong15%
  • India10%
  • Malaysia / Thailand / Indonesia / Vietnam / Philippines20%
  • Australia / New Zealand5%
  • US / Europe / Others5%

By Company Profiles

  • Biopharma & Big Pharma55%
  • Technology / Solution Providers25%
  • CDMOs / CMOs15%
  • Government / Academics / Research Institutes / Associations5%

Knowledge Hub

Download content relating to this event and topic.

Want to Sponsor This Event?

Explore sponsorship opportunities and discover how your brand can connect with key decision-makers across the industry.

Speak with our Sponsorship Team

Roshinee Singh

Head of Business Development

roshinee.singh@connexiusgroup.com

Jack Baclaan

Business Development Manager

jack.baclaan@connexiusgroup.com

Jumarie Albit

Business Development Manager

jumarie.albit@connexiusgroup.com

Register

Contact us for group bookings of three or more delegates.

Delegate Category
Super Early Bird Rate
Valid until 31st January 2028
Early Bird Rate
Valid until 31st March 2028
Standard Rate
Biopharma, Big Pharma, Academics, Research Institutes & GovernmentSGD 699SGD 899SGD 1,099
Service & Solution ProviderSGD 2,049SGD 2,249SGD 2,449

INSIGHTS

  • BiopharmaMarket insight

    Could Four 2,000 L Single-Use Bioreactors Outperform One 10,000 L Stainless-Steel Reactor?

    Biologics manufacturing productivity depends on more than installed bioreactor volume. This article compares four 2,000 L single-use bioreactors with one 10,000 L stainless-steel reactor and examines how turnaround time, utilisation, titre, downstream capacity and manufacturing strategy can determine annual output.

    Read more: Could Four 2,000 L Single-Use Bioreactors Outperform One 10,000 L Stainless-Steel Reactor?
  • BiopharmaMarket insight

    Stainless Steel vs Single-Use: Why Biomanufacturing Still Needs Both

    Stainless steel and single-use systems serve different roles in modern biomanufacturing, with the right choice depending on production volume, product mix and demand certainty. This article examines how leading APAC facilities are combining scale, flexibility and resilience through steel, single-use and hybrid manufacturing strategies.

    Read more: Stainless Steel vs Single-Use: Why Biomanufacturing Still Needs Both
  • BiopharmaIndustry article

    Eppendorf Breaks Ground on a EUR 40 Million Production Site in Penang, Malaysia

    On 12 November 2026, Eppendorf SE broke ground on a new production facility at Bandar Cassia Technology Park in Penang. The EUR 40 million investment is the company's first manufacturing operation in Southeast Asia and will produce selected products from its Centrifuges & Instruments portfolio for laboratories worldwide, with production starting gradually in 2028.

    Read more: Eppendorf Breaks Ground on a EUR 40 Million Production Site in Penang, Malaysia